Report: Pharma missing Big Data opportunity by ignoring social media
Inherent conservatism and a lack of regulatory guidance have caused pharma to edge slowly onto social media platforms. While such reticence is understandable, patients still talk about their health online. The question is, should drugmakers be listening?
Source: Social Media News Feed By Google